HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

COACH trial: a randomized controlled trial of nurse practitioner/community health worker cardiovascular disease risk reduction in urban community health centers: rationale and design.

AbstractBACKGROUND:
Despite well-publicized guidelines on the appropriate management of cardiovascular disease (CVD) and type 2 diabetes, implementation of risk-reducing practices remains poor. This paper describes the rationale and design of a randomized controlled clinical trial evaluating the effectiveness of a comprehensive program of CVD risk reduction delivered by nurse practitioner (NP)/community health worker (CHW) teams versus enhanced usual care in improving the proportion of patients in urban community health centers who achieve goal levels recommended by national guidelines for lipids, blood pressure, HbA1c and prescription of appropriate medications.
METHODS:
The COACH (Community Outreach and Cardiovascular Health) trial is a randomized controlled trial in which patients at federally-qualified community health centers were randomly assigned to one of two groups: comprehensive intensive management of CVD risk factors for one year by a NP/CHW team or an enhanced usual care control group.
RESULTS:
A total of 3899 patients were assessed for eligibility and 525 were randomized. Groups were comparable at baseline on sociodemographic and clinical characteristics with the exception of statistically significant differences in total cholesterol and hemoglobin A1c.
CONCLUSIONS:
This study is a novel amalgam of multilevel interdisciplinary strategies to translate highly efficacious therapies to low-income federally-funded health centers that care for patients who carry a disproportionate burden of CVD, type 2 diabetes and uncontrolled CVD risk factors. The impact of such a community clinic-based intervention is potentially enormous.
AuthorsJerilyn K Allen, Cheryl R Dennison Himmelfarb, Sarah L Szanton, Lee Bone, Martha N Hill, David M Levine
JournalContemporary clinical trials (Contemp Clin Trials) Vol. 32 Issue 3 Pg. 403-11 (May 2011) ISSN: 1559-2030 [Electronic] United States
PMID21241828 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Chemical References
  • Glycated Hemoglobin A
  • Lipids
Topics
  • Adult
  • Aged
  • Baltimore
  • Blood Pressure
  • Cardiovascular Diseases (prevention & control)
  • Community Health Centers
  • Community Health Workers
  • Diabetes Mellitus, Type 2 (blood, prevention & control)
  • Female
  • Glycated Hemoglobin
  • Health Promotion (economics, methods)
  • Humans
  • Insurance, Health
  • Life Style
  • Lipids (blood)
  • Male
  • Medication Therapy Management
  • Middle Aged
  • Nurse Practitioners
  • Research Design
  • Risk Reduction Behavior
  • Socioeconomic Factors
  • Urban Population

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: